BROOKLYN IMMUNOTHERAPEUTICS's ticker is and the CUSIP is 114082950. A total of 3 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $11,000 | +450.0% | 5,000 | -5.7% | 0.00% | – |
| Q2 2022 | $2,000 | -83.3% | 5,300 | -10.2% | 0.00% | – |
| Q1 2022 | $12,000 | -68.4% | 5,900 | -35.9% | 0.00% | – |
| Q4 2021 | $38,000 | -96.1% | 9,200 | -83.8% | 0.00% | -100.0% |
| Q3 2021 | $968,000 | -4.3% | 56,800 | +1.1% | 0.00% | 0.0% |
| Q2 2021 | $1,012,000 | – | 56,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 11,400 | $48,000 | 0.00% |
| SIMPLEX TRADING, LLC | 9,200 | $38,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |